Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes

INTRODUCTION Radiotherapy outcomes might be further improved by a greater understanding of the individual variations in normal tissue reactions that determine tolerance. Most published studies on radiation toxicity have been performed retrospectively. Our prospective study was launched in 1996 to measure the in vitro radiosensitivity of peripheral blood lymphocytes before treatment with radical radiotherapy in patients with breast cancer, and to assess the early and the late radiation skin side effects in the same group of patients. We prospectively recruited consecutive breast cancer patients receiving radiation therapy after breast surgery. To evaluate whether early and late side effects of radiotherapy can be predicted by the assay, a study was conducted of the association between the results of in vitro radiosensitivity tests and acute and late adverse radiation effects. METHODS Intrinsic molecular radiosensitivity was measured by using an initial radiation-induced DNA damage assay on lymphocytes obtained from breast cancer patients before radiotherapy. Acute reactions were assessed in 108 of these patients on the last treatment day. Late morbidity was assessed after 7 years of follow-up in some of these patients. The Radiation Therapy Oncology Group (RTOG) morbidity score system was used for both assessments. RESULTS Radiosensitivity values obtained using the in vitro test showed no relation with the acute or late adverse skin reactions observed. There was no evidence of a relation between acute and late normal tissue reactions assessed in the same patients. A positive relation was found between the treatment volume and both early and late side effects. CONCLUSION After radiation treatment, a number of cells containing major changes can have a long survival and disappear very slowly, becoming a chronic focus of immunological system stimulation. This stimulation can produce, in a stochastic manner, late radiation-related adverse effects of varying severity. Further research is warranted to identify the major determinants of normal tissue radiation response to make it possible to individualize treatments and improve the outcome of radiotherapy in cancer patients.

Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy

BACKGROUND. Either higher levels of initial DNA damage or lower levels of radiation-induced apoptosis in peripheral blood lymphocytes have been associated to increased risk for develop late radiation-induced toxicity. It has been recently published that these two predictive tests are inversely related. The aim of the present study was to investigate the combined role of both tests in relation to clinical radiation-induced toxicity in a set of breast cancer patients treated with high dose hyperfractionated radical radiotherapy. METHODS. Peripheral blood lymphocytes were taken from 26 consecutive patients with locally advanced breast carcinoma treated with high-dose hyperfractioned radical radiotherapy. Acute and late cutaneous and subcutaneous toxicity was evaluated using the Radiation Therapy Oncology Group morbidity scoring schema. The mean follow-up of survivors (n = 13) was 197.23 months. Radiosensitivity of lymphocytes was quantified as the initial number of DNA double-strand breaks induced per Gy and per DNA unit (200 Mbp). Radiation-induced apoptosis (RIA) at 1, 2 and 8 Gy was measured by flow cytometry using annexin V/propidium iodide. RESULTS. Mean DSB/Gy/DNA unit obtained was 1.70 ± 0.83 (range 0.63-4.08; median, 1.46). Radiation-induced apoptosis increased with radiation dose (median 12.36, 17.79 and 24.83 for 1, 2, and 8 Gy respectively). We observed that those "expected resistant patients" (DSB values lower than 1.78 DSB/Gy per 200 Mbp and RIA values over 9.58, 14.40 or 24.83 for 1, 2 and 8 Gy respectively) were at low risk of suffer severe subcutaneous late toxicity (HR 0.223, 95%CI 0.073-0.678, P = 0.008; HR 0.206, 95%CI 0.063-0.677, P = 0.009; HR 0.239, 95%CI 0.062-0.929, P = 0.039, for RIA at 1, 2 and 8 Gy respectively) in multivariate analysis. CONCLUSIONS. A radiation-resistant profile is proposed, where those patients who presented lower levels of initial DNA damage and higher levels of radiation induced apoptosis were at low risk of suffer severe subcutaneous late toxicity after clinical treatment at high radiation doses in our series. However, due to the small sample size, other prospective studies with higher number of patients are needed to validate these results.

Efectos del consumo de aceites termo-oxidados sobre la peroxidación lipídica en animales de laboratorio.

INTRODUCTION The quality of fats and oils used for frying is as important as the quality of the final product since during the frying process oxidization by-products are formed and become part of the diet, being potentially harmful for the consumers' health. OBJECTIVE To determine the effects of thermo-oxidised fats and oils on the oxidization of plasma lipoproteins inexperimental rats. METHODS Determination by means of spectrophotometric techniques of those substances reacting with thiobarbituric acid and total cholesterol (enzymatic method) in the sera of 40 Wistar rats that consumed crude thermooxidised oils and fats with different levels of malonil aldehyde(MDA) for 30 days. RESULTS The group of rats receiving a diet with thermooxidised oils and fats experienced significant increases in MDA plasma levels throughout the study period, lipid peroxidation being higher with increasing MDA content (p < 0.05) regardless the type of fat compound consumed. However, those rats receiving crude oils and fats kept plasma levels of lipidic peroxides without significant changes throughout the experimental period (p > 0.05). By contrast, cholesterol levels increased towards the end of the experimental period in both the rats consuming crude fats and those consuming thermo-oxidised fats (p < 0.05). CONCLUSIONS Consumption of oils and fats submitted to repeat thermal heating has an influence on plasma lipidic peroxidation, which becomes higher with increasing number of heating processes applied, so that it would advisable not to abuse of reheating the oils used for frying foods.

The diamine oxidase gene is associated with hypersensitivity response to non-steroidal anti-inflammatory drugs.

Non-steroidal anti-inflammatory drugs (NSAIDs) are the drugs most frequently involved in hypersensitivity drug reactions. Histamine is released in the allergic response to NSAIDs and is responsible for some of the clinical symptoms. The aim of this study is to analyze clinical association of functional polymorphisms in the genes coding for enzymes involved in histamine homeostasis with hypersensitivity response to NSAIDs. We studied a cohort of 442 unrelated Caucasian patients with hypersensitivity to NSAIDs. Patients who experienced three or more episodes with two or more different NSAIDs were included. If this requirement was not met diagnosis was established by challenge. A total of 414 healthy unrelated controls ethnically matched with patients and from the same geographic area were recruited. Analyses of the SNPs rs17740607, rs2073440, rs1801105, rs2052129, rs10156191, rs1049742 and rs1049793 in the HDC, HNMT and DAO genes were carried out by means of TaqMan assays. The detrimental DAO 16 Met allele (rs10156191), which causes decreased metabolic capacity, is overrepresented among patients with crossed-hypersensitivity to NSAIDs with an OR  = 1.7 (95% CI  = 1.3-2.1; Pc  = 0.0003) with a gene-dose effect (P = 0.0001). The association was replicated in two populations from different geographic areas (Pc  = 0.008 and Pc  = 0.004, respectively). CONCLUSIONS AND IMPLICATIONS: The DAO polymorphism rs10156191 which causes impaired metabolism of circulating histamine is associated with the clinical response in crossed-hypersensitivity to NSAIDs and could be used as a biomarker of response.

Influència del clima en la fenologia de la floració de Globularia alypum: anàlisi a partir de mostres d'herbari

Globularia alypum és un arbust termòfil típic de la regió oest del Mediterrani. Aquest nanofaneròfit té un patró de floració molt ampli. Les poblacions primerenques floreixen des del Juliol fins al Desembre i les poblacions tardanes des del Gener fins a l’Abril. L’objectiu del projecte és esbrinar quins factors climàtics determinen la fenologia de la floració de l’espècie a partir de mostres d’herbari i conèixer l’abast geogràfic d’ambdós patrons de floració a la península Ibèrica i França. També l’estudi d’altres característiques fenològiques en relació amb el clima: els braquiblasts i les espigues de capítols. Els plecs d’herbari han estat georeferenciats per ser utilitzats en un entorn SIG junt amb les dades del clima i s’ha realitzat una anàlisi estadística. El resultats mostren que les poblacions primerenques creixen majoritàriament en zones costaneres mentre que les tardanes ho fan en zones continentals. Les poblacions primerenques creixen en àrees on les temperatures (mitjana, mínima, màxima i mínima del mes més fred) són més altes que les tardanes per l’efecte temperador del mar. Al analitzar totes les poblacions, el nombre de mesos des de la transició floral es correlaciona negativament amb la temperatura mínima mensual i la temperatura mitjana mensual en tots els mesos, mentre que amb la temperatura màxima mensual entre Octubre i Abril. Al estudiar sols les poblacions tardanes les correlacions són similars, però no en les primerenques on no se’n troba cap. Les correlacions entre el nombre de mesos des de la transició floral i les variables climàtiques anuals són iguals, a més de trobar-se una correlació negativa amb la temperatura mínima del mes més fred i l’índex tèrmic, i positiva amb l’índex de continentalitat. No s’ha trobat cap diferència en presència de braquiblasts segons la població, però sí en les espigues de capítols, essent més freqüents en les poblacions primerenques. Es suggereix que la temperatura és un factor més determinant per a les poblacions tardanes, mentre que es desconeix si és la precipitació en les primerenques. Tampoc es té coneixement sobre si les diferències entre els dos patrons són genètiques o fenotípiques i quin mecanisme possibilita el desenvolupament de braquiblasts i espigues de capítols.

PARP inhibition attenuates histopathological lesion in ischemia/reperfusion renal mouse model after cold prolonged ischemia.

We test the hypothesis that PARP inhibition can decrease acute tubular necrosis (ATN) and other renal lesions related to prolonged cold ischemia/reperfusion (IR) in kidneys preserved at 4°C in University of Wisconsin (UW) solution. Material and Methods. We used 30 male Parp1(+/+) wild-type and 15 male Parp1(0/0) knockout C57BL/6 mice. Fifteen of these wild-type mice were pretreated with 3,4-dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2H)-isoquinolinone (DPQ) at a concentration of 15 mg/kg body weight, used as PARP inhibitor. Subgroups of mice were established (A: IR 45 min/6 h; B: IR + 48 h in UW solution; and C: IR + 48 h in UW solution plus DPQ). We processed samples for morphological, immunohistochemical, ultrastructural, and western-blotting studies. Results. Prolonged cold ischemia time in UW solution increased PARP-1 expression and kidney injury. Preconditioning with PARP inhibitor DPQ plus DPQ supplementation in UW solution decreased PARP-1 nuclear expression in renal tubules and renal damage. Parp1(0/0) knockout mice were more resistant to IR-induced renal lesion. In conclusion, PARP inhibition attenuates ATN and other IR-related renal lesions in mouse kidneys under prolonged cold storage in UW solution. If confirmed, these data suggest that pharmacological manipulation of PARP activity may have salutary effects in cold-stored organs at transplantation.

THCCOOH concentrations in whole blood: Are they useful in discriminating occasional from heavy smokers?

Some forensic and clinical circumstances require knowledge of the frequency of drug use. Care of the patient, administrative, and legal consequences will be different if the subject is a regular or an occasional cannabis smoker. To this end, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH) has been proposed as a criterion to help to distinguish between these two groups of users. However, to date this indicator has not been adequately assessed under experimental conditions. We carried out a controlled administration study of smoked cannabis with a placebo. Cannabinoid levels were determined in whole blood using tandem mass spectrometry. Significantly high differences in THCCOOH concentrations were found between the two groups when measured during the screening visit, prior to the smoking session, and throughout the day of the experiment. Receiver operating characteristic (ROC) curves were determined and two threshold criteria were proposed in order to distinguish between these groups: a free THCCOOH concentration below 3 µg/L suggested an occasional consumption (≤ 1 joint/week) while a concentration higher than 40 µg/L corresponded to a heavy use (≥ 10 joints/month). These thresholds were tested and found to be consistent with previously published experimental data. The decision threshold of 40 µg/L could be a cut-off for possible disqualification for driving while under the influence of cannabis. A further medical assessment and follow-up would be necessary for the reissuing of a driving license once abstinence from cannabis has been demonstrated. A THCCOOH level below 3 µg/L would indicate that no medical assessment is required. Copyright © 2013 John Wiley & Sons, Ltd.

PARP inhibition attenuates histopathological lesion in ischemia/reperfusion renal mouse model after cold prolonged ischemia.

We test the hypothesis that PARP inhibition can decrease acute tubular necrosis (ATN) and other renal lesions related to prolonged cold ischemia/reperfusion (IR) in kidneys preserved at 4°C in University of Wisconsin (UW) solution. Material and Methods. We used 30 male Parp1(+/+) wild-type and 15 male Parp1(0/0) knockout C57BL/6 mice. Fifteen of these wild-type mice were pretreated with 3,4-dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2H)-isoquinolinone (DPQ) at a concentration of 15 mg/kg body weight, used as PARP inhibitor. Subgroups of mice were established (A: IR 45 min/6 h; B: IR + 48 h in UW solution; and C: IR + 48 h in UW solution plus DPQ). We processed samples for morphological, immunohistochemical, ultrastructural, and western-blotting studies. Results. Prolonged cold ischemia time in UW solution increased PARP-1 expression and kidney injury. Preconditioning with PARP inhibitor DPQ plus DPQ supplementation in UW solution decreased PARP-1 nuclear expression in renal tubules and renal damage. Parp1(0/0) knockout mice were more resistant to IR-induced renal lesion. In conclusion, PARP inhibition attenuates ATN and other IR-related renal lesions in mouse kidneys under prolonged cold storage in UW solution. If confirmed, these data suggest that pharmacological manipulation of PARP activity may have salutary effects in cold-stored organs at transplantation.

Estudio de parámetros gasométricos en sangre pre y post oclusión en el ictus agudo isquemico

Durante los procedimientos endovasculares en el ictus isquémico la información per-procedimiento del daño cerebral ayudaría a tomar decisiones sobre intentar la recanalización arterial. Métodos Se estudiaron parámetros gasométricos de sangre extraída durante los procedimientos endovasculares de recanalización. Se obtuvieron muestras proximal y distal a la oclusión. Un estudio gasométrico se realizo inmediatamente. Resultados El estudio mostró diferencias significativas entre las muestras pre-oclusión y postoclusión en la presión parcial de oxígeno (PaO2Pre78,9±16.3mmHgVs73.4±14.9 mmHg,p&0,001). Una curva ROC determinó que una Post-PaO2&70 mmHg predice mejoría clínica. Los pacientes con post-PaO2&70mmHg tuvieron mejor autonomía (medianaMRS:3Vs.6, p=0,024). En el análisis multivariante el único predictor independiente de mejoría clínica fue la Post-PaO2&70(OR:5,21IC95%:1.38-67.24,p=0,013). Conclusión Es posible la obtención de muestras de sangre del tejido lesionado distal a la oclusión. La información puede ser utilizada para predecir evolución clínica y en las decisiones durante el procedimiento.

Determinants for membrane association of the hepatitis C virus NS2 protease domain.

Hepatitis C virus (HCV) nonstructural protein 2 (NS2) is required for HCV polyprotein processing and particle assembly. It comprises an N-terminal membrane domain and a C-terminal, cytosolically oriented protease domain. Here, we demonstrate that the NS2 protease domain itself associates with cellular membranes. A single charged residue in the second α-helix of the NS2 protease domain is required for proper membrane association, NS2 protein stability, and efficient HCV polyprotein processing.

Use of the comet test to assess DNA damage in children with ataxia-telangiectasia and their relatives.

The electrophoresis of cells in alkaline medium (comet assay) is a valid technique for quantifying DNA damage in patients with ataxia-telangiectasia and their relatives.

La privació de la pàtria potestat en el dret civil català

La privació de la potestat dels pares és una mesura per protegir un menor d’edat davant un dany que els seus progenitors no poden o no volen evitar. La inhabilitació per l’exercici del dret de pàtria potestat és una pena que no sempre aconsegueix l’adequada protecció dels menors d’edat.

Gestió i informació de la planificació de rutes aèries

Projecte final de carrera corresponent a l'àrea de J2EE. La temàtica del projecte es basa en el desenvolupament d'una eina empresarial per a la gestió d'alguns dels recursos d'una companyia aèria.

Formación de nanoestructuras de silicio por evaporación térmica y pulverización catódica. Intento de crecimiento de nanohilos de silicio

El proyecto tiene como objetivo estudiar las posibilidades de síntesis de nanohilos de silicio mediante evaporación térmica y pulverización catódica. Con estas técnicas se pretende lograr un crecimiento aditivo en un escenario VLS (Vapor Liquid Solid). Se han utilizado obleas de silicio recubiertas de oro o aluminio como catalizador, sometidas a un tratamiento térmico para lograr una aleación eutéctica. Se han realizado 19 ensayos variando los parámetros experimentales, y se han obtenido 44 muestras diferentes, caracterizadas mediante SEM. Después de un estudio exhaustivo no se ha podido hacer crecer nanohilos de silicio, confirmando la dificultad de su obtención con las técnicas propuestas.

Comparativa de equipos de síntesis mecánica : aleaciones de base Al-Cu y Fe-Ni

La síntesis mecánica es un proceso basado en la molturación de una mezcla de polvosometida a altas energías que se producen por los choques entre las partículas y lasbolas de un micromolino, entre las partículas y las paredes del recipiente y entre lasmismas partículas. Los dos procesos involucrados en el proceso de síntesis mecánicason la soldadura en frío y la fractura.El proyecto que se presenta es una continuación de los diferentes estudios realizadosen el departamento de Recerca de Materials i Termodinàmica de la Universidad deGirona sobre el proceso de aleado mecánico, en especial del proyecto de Ivan Darnés(Abril 2005) donde se realizaba un estudio comparativo de los micromolinosPulverisette 7 (P7) y SPEX8000 a partir de dos aleaciones en polvo de base Fe.El presente proyecto tiene como objetivo principal realizar nuevamente unacomparación de los equipos P7 y SPEX8000, pero utilizando otras mezclas de polvoiniciales y modificando los parámetros del proceso. Para tal comparación se estudiaránlas muestras obtenidas a nivel estructural, térmico y morfológico